WAKEFIELD, Mass., April 05, 2016 -- Edgewater Technology, Inc. (NASDAQ:EDGW) (Edgewater), a leading consulting firm that brings a blend of classic and product-based consulting services to its clients, will hold a conference call for analysts on Wednesday, May 4, 2016 at 10:00 a.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2016. The company will issue its financial results in a press release prior to the call.
Date: Wednesday, May 4, 2016
Time: 10:00 a.m. Eastern time
Dial-in number: 1-877-713-9347 / Passcode: 82810839
Webcast: http://ir.edgewater.com/
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization.
Edgewater’s news release containing the first quarter 2016 financial results will be released prior to the market opening on the day of the call. A replay of the conference call can be accessed via Edgewater’s investor relations web site at http://ir.edgewater.com/ or by dialing 1-404-537-3406 (Conference ID#: 82810839) after 1:00 p.m. Eastern time on the same day through Wednesday, May 18, 2016.
About Edgewater
Edgewater Technology, Inc. (NASDAQ:EDGW) is a strategic consulting firm delivering a blend of classic and product-based consulting services. Edgewater addresses the market both vertically by industry and horizontally by product and technology specialty, providing its client base with a wide range of business and technology solutions. As one of the largest IT consulting firms based in New England, the company works with clients to reduce costs, improve processes and increase revenue through the judicious use of technology. Edgewater’s brand names include Edgewater Technology, Edgewater Ranzal and Edgewater Fullscope. To learn more, please visit www.edgewater.com.
Safe Harbor for Forward-Looking Statements
During the course of the conference call, Edgewater may make forward-looking statements regarding future events or the future financial performance of the Company. Statements including words such as "anticipate," "believe,” "estimate" or "expect" and statements in the future tense are forward-looking statements. These forward-looking statements are subject to risks and uncertainties that could cause actual events or actual future results to differ materially from those set forth in the forward-looking statements. Please refer to Edgewater’s latest Annual Report on Form 10-K for the fiscal year ended December 31, 2014 for a discussion of important factors that could cause actual events or actual results to differ materially from those discussed during the conference call.
Company Contact: Timothy R. Oakes, Chief Financial Officer 1-781-246-3343 Investor Relations Contact: Three Part Advisors, LLC Steven Hooser / Matt Selinger 1-817-778-8423


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FDA Approves Mitapivat for Anemia in Thalassemia Patients 



